Drug Profile
SR 3727
Alternative Names: SR 3727ALatest Information Update: 19 Jan 1995
Price :
$50
*
At a glance
- Originator SRI International
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action DNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpesvirus infections
Most Recent Events
- 19 Jan 1995 No-Development-Reported for Herpesvirus infections in USA (Unknown route)
- 28 Nov 1994 Preclinical development for Herpesvirus infections in USA (Unknown route)